These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 12738734

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D, Stenzinger A, Klauschen F, Stephan C, Jung K, Erbersdobler A, Rabien A.
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [Abstract] [Full Text] [Related]

  • 23. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E, Schmalfeldt B, Konik E, Späthe K, Härting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W.
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, Nosho K, Imsumran A, Fujita M, Hosokawa M, Hinoda Y, Imai K.
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [Abstract] [Full Text] [Related]

  • 26. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
    Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, Talieri M.
    Br J Cancer; 2001 Jun 01; 84(11):1488-96. PubMed ID: 11384099
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
    Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, Patel PS.
    J Surg Oncol; 2005 May 01; 90(2):81-8. PubMed ID: 15844188
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
    Bérubé M, Deschambeault A, Boucher M, Germain L, Petitclerc E, Guérin SL.
    Mol Vis; 2005 Dec 14; 11():1101-11. PubMed ID: 16379022
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS.
    Clin Cancer Res; 2002 Sep 14; 8(9):2894-901. PubMed ID: 12231534
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.